Af­ter a one-year gap, Sage fi­nal­ly finds new CMO; Gut­ted by lay­offs, Flag­ship's Ru­bius reshuf­fles a not-so-full deck

Late last year, Sage’s chief med­ical of­fi­cer Stephen Kanes left to head a new de­pres­sion drug de­vel­op­er in An­co­ra. Now, one year lat­er, Sage has fi­nal­ly found his re­place­ment in Lau­ra Gault.

Gault comes to Sage from Alex­ion, As­traZeneca’s rare dis­ease arm, where she was head of neu­rol­o­gy and oph­thal­mol­o­gy and led the Ul­tomiris pro­gram for myas­the­nia gravis and NMOSD. In April, Ul­tomiris was ap­proved for adults with myas­the­nia gravis.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.